Pages that link to "Q37498549"
Jump to navigation
Jump to search
The following pages link to Pharmacogenetics of smoking cessation therapy. (Q37498549):
Displaying 18 items.
- Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities (Q33706037) (← links)
- Pathways to precision medicine in smoking cessation treatments (Q34527740) (← links)
- Genome sequencing of idiopathic pulmonary fibrosis in conjunction with a medical school human anatomy course (Q35239965) (← links)
- CYP2A6 Polymorphisms May Strengthen Individualized Treatment for Nicotine Dependence (Q35594492) (← links)
- Knowledge, attitudes and preferences regarding genetic testing for smoking cessation. A cross-sectional survey among Dutch smokers (Q35659842) (← links)
- A genetic instrumental variables analysis of the effects of prenatal smoking on birth weight: evidence from two samples (Q35669154) (← links)
- Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials (Q35679980) (← links)
- Biomarkers to Optimize the Treatment of Nicotine Dependence (Q35773685) (← links)
- Predictors of relapse in a bupropion trial for smoking cessation in recently-abstinent alcoholics: preliminary results using an aggregate genetic risk score (Q36286817) (← links)
- Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study (Q36727883) (← links)
- Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature. (Q36868963) (← links)
- Nicotine vaccines to assist with smoking cessation: current status of research (Q36987118) (← links)
- APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset (Q37008969) (← links)
- Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion (Q37325773) (← links)
- Chronic disease, medications and lifestyle: perceptions from a regional Victorian Aboriginal community (Q37334540) (← links)
- Bumps along the translational pathway: anticipating uptake of tailored smoking cessation treatment (Q37438867) (← links)
- Pharmacotherapy for smoking cessation: current advances and research topics (Q37863092) (← links)
- Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies. (Q47157570) (← links)